The FINANCIAL — Allergan plc on August 20 announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s resubmission of its Supplemental Biologics License Application (sBLA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results